{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:38:01Z","timestamp":1793637481114,"version":"4.5.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1752-1947-4-298","type":"journal-article","created":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T18:14:56Z","timestamp":1283364896000},"source":"Crossref","is-referenced-by-count":15,"title":["Amyotrophic lateral sclerosis-motor neuron disease, monoclonal gammopathy, hyperparathyroidism, and B12 deficiency: case report and review of the literature"],"prefix":"10.1186","volume":"4","author":[{"given":"Richard A","family":"Rison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said R","family":"Beydoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,9,1]]},"reference":[{"key":"1255_CR1","first-page":"2247","volume-title":"Neurology in Clinical Practice: The Neurological Disorders","author":"WG Bradley","year":"2004","unstructured":"Bradley WG, Daroff RB, Fenichl GM, Jankovic J: Neurology in Clinical Practice: The Neurological Disorders. 2004, Butterworth Heinemann, 2: 2247."},{"key":"1255_CR2","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJM199403033300901","volume":"330","author":"G Bensimon","year":"1994","unstructured":"Bensimon G, Lacomblez L, Meininger V, the ALS\/Riluzole Study group: A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med. 1994, 330: 585-591. 10.1056\/NEJM199403033300901.","journal-title":"N Engl J Med"},{"key":"1255_CR3","volume-title":"MedLink Neurology","author":"ME Alexianu","year":"2006","unstructured":"Alexianu ME, Ciabarra AM, Latov N: Neuropathies associated with monoclonal gammopathies. MedLink Neurology. Edited by: Gilman S. 2006, San Diego, CA: MedLink Corporation"},{"key":"1255_CR4","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1212\/WNL.31.11.1480","volume":"31","author":"JJ Kelly","year":"1981","unstructured":"Kelly JJ, Kyle RA, O'Brien PC, Dyck PJ: Prevalence of monoclonal protein in peripheral neuropathy. Neurology. 1981, 31: 1480-1483.","journal-title":"Neurology"},{"key":"1255_CR5","first-page":"530","volume":"92","author":"A Di Saverio","year":"2001","unstructured":"Di Saverio A, Quaglino D: Association between motoneuron disease and Waldenstrom macroglobunemia. Recenti Prog Med. 2001, 92: 530-532.","journal-title":"Recenti Prog Med"},{"key":"1255_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1600-0404.1984.tb00802.x","volume":"70","author":"BM Patten","year":"1984","unstructured":"Patten BM: Neuropathy and motor neuron syndromes associated with plasma cell disease. Acta Neurol Scand. 1984, 70: 47-61. 10.1111\/j.1600-0404.1984.tb00802.x.","journal-title":"Acta Neurol Scand"},{"key":"1255_CR7","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1212\/WNL.48.6.1671","volume":"48","author":"PH Gordon","year":"1997","unstructured":"Gordon PH, Rowland LP, Younger DS, Sherman WH, Hays AP, Louis ED, Lange DJ, Trojaborg W, Lovelace RE, Murphy PL: Lymphoproliferative disorders and motor neuron disease: an update. Neurology. 1997, 48: 1671-1678.","journal-title":"Neurology"},{"key":"1255_CR8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/ana.410290114","volume":"29","author":"DS Younger","year":"1991","unstructured":"Younger DS, Rowland LP, Latov N, Hays AP, Lang DJ, Sherman W, Inghirami G, Pesce MA, Knowles DM, Powers J, Miller JR, Fetell MR, Lovelace RE: Lymphoma, motor neuron disease, and amyotrophic lateral sclerosis. Ann Neurol. 1991, 29: 78-86. 10.1002\/ana.410290114.","journal-title":"Ann Neurol"},{"key":"1255_CR9","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/ana.410110515","volume":"11","author":"LP Rowland","year":"1982","unstructured":"Rowland LP, Defendini R, Sherman W, Hirano A, Olarte MR, Latov N, Lovelace RE, Inoue K, Osserman EF: Macroglobunemia with peripheral neuropathy simulating motor neuron disease. Ann Neurol. 1982, 11: 532-536. 10.1002\/ana.410110515.","journal-title":"Ann Neurol"},{"key":"1255_CR10","first-page":"273","volume":"36","author":"N Latov","year":"1982","unstructured":"Latov N: Plasma cell dyscrasia and motor neuron disease. Adv Neurol. 1982, 36: 273-279.","journal-title":"Adv Neurol"},{"key":"1255_CR11","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1212\/WNL.36.11.1429","volume":"36","author":"ME Shy","year":"1986","unstructured":"Shy ME, Rowland LP, Smith T, Trojaborg W, Latov N, Sherman W, Pesce MA, Lovelace RE, Osserman EF: Motor neuron disease and plasma cell dyscrasia. Neurology. 1986, 36: 1429-1436.","journal-title":"Neurology"},{"key":"1255_CR12","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1212\/WNL.37.2.335","volume":"37","author":"S Rudnicki","year":"1987","unstructured":"Rudnicki S, Chad DA, Drachman DA, Smith TW, Anwer UE, Levitan N: Motor neuron disease and paraproteinemia. Neurology. 1987, 37: 335-337.","journal-title":"Neurology"},{"key":"1255_CR13","first-page":"215","volume-title":"Neuromuscular disorders associated with monoclonal immunoglobulins (abstract)","author":"G Merlini","year":"1989","unstructured":"Merlini G, Rutigliano L, Masnaghetti S: Neuromuscular disorders associated with monoclonal immunoglobulins (abstract). International Conference on Multiple Myeloma. Biology, Pathophysiology, Prognosis and Treatment: Abstracts. 1989, Bologna, Italy, 215."},{"key":"1255_CR14","first-page":"1146","volume":"32","author":"T Saito","year":"1992","unstructured":"Saito T, Irie S, Ito H, Kowa H: Paraproteinemia and motor neuron disease. Rinsho Shinkeigaku. 1992, 32: 1146-1148.","journal-title":"Rinsho Shinkeigaku"},{"key":"1255_CR15","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1159\/000117102","volume":"35","author":"D Lavrni\u0107","year":"1995","unstructured":"Lavrni\u0107 D, Vidakovic A, Miletic V, Trikic R, Marinkovic Z, Rakocevic V, Nikolic J, Wirguin I, Sadiq SA, Apostolski S: Motor neuron disease and monoclonal gammopathy. Eur Neurol. 1995, 35: 104-107. 10.1159\/000117102.","journal-title":"Eur Neurol"},{"key":"1255_CR16","first-page":"513","volume":"6","author":"K Hirschberg","year":"1889","unstructured":"Hirschberg K: Qur kenntnisse der osseomalacie und ostitis malacissans. Beitr Pathol. 1889, 6: 513-524.","journal-title":"Beitr Pathol"},{"key":"1255_CR17","first-page":"181","volume-title":"Human Motor Neuron Disorders","author":"BM Patten","year":"1982","unstructured":"Patten BM, Engel WK: Phosphate and parathyroid disorders associated with the syndrome of amyotrophic lateral sclerosis. Human Motor Neuron Disorders. Edited by: Rowland LP. 1982, New York: Raven Press, 181-200."},{"key":"1255_CR18","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1590\/S0004-282X2005000100029","volume":"63","author":"AA Carvalho","year":"2005","unstructured":"Carvalho AA, Vieira A, Simplicio H, Fugygara S, Carvalho SM, Rigueiro MP: Primary hyperparathyroidism simulating motor neuron disease: case report. Arq Neuropsiquiatr. 2005, 63: 160-162.","journal-title":"Arq Neuropsiquiatr"},{"key":"1255_CR19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.33588\/rn.3602.2002255","volume":"36","author":"GE Rodriguez","year":"2003","unstructured":"Rodriguez GE, Califano IM, Alurralde AM, Ercolano M, Silva MC, Sica REP: Amyotrophic lateral sclerosis: it's relationship with thyroid function and phosphate calcium metabolism. Revista de Neurologica. 2003, 36: 104-108.","journal-title":"Revista de Neurologica"},{"key":"1255_CR20","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1212\/WNL.50.6.1795","volume":"50","author":"CE Jackson","year":"1998","unstructured":"Jackson CE, Amato AA, Bryan WW, Wolfe GI, Sakhaee K, Barohn RJ: Primary hyperparathyroidism and ALS: is there a relation?. Neurology. 1998, 50: 1795-1799.","journal-title":"Neurology"},{"key":"1255_CR21","first-page":"318","volume":"37","author":"BM Patten","year":"1976","unstructured":"Patten BM, Mallette LE: Motor neuron disease: retrospective study of associated abnormalities. Dis Nerv Syst. 1976, 37: 318-321.","journal-title":"Dis Nerv Syst"},{"key":"1255_CR22","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1212\/WNL.45.7.1340","volume":"45","author":"JE Ahlskog","year":"1995","unstructured":"Ahlskog JE, Waring SC, Kurland LT, Petersen RC, Moyer TP, Harmsen WS, Maraganore DM, O'Brien PC, Esteban-Santillan C, Bush V: Guamanian neurodegenerative disease: investigation of the calcium metabolism\/heavy metal hypothesis. Neurology. 1995, 45: 1340-1344.","journal-title":"Neurology"},{"key":"1255_CR23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1159\/000117447","volume":"37","author":"Y Sato","year":"1997","unstructured":"Sato Y, Honda Y, Asoh T, Kikuyama M, Oizumi K: Hypovitaminosis D and decreased bone mineral density in amyotrophic lateral sclerosis. Eur Neurol. 1997, 37: 225-229. 10.1159\/000117447.","journal-title":"Eur Neurol"},{"key":"1255_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/14660820050515115","volume":"1","author":"CH Whitaker","year":"2000","unstructured":"Whitaker CH, Malchoff CD, Felice KJ: Treatable lower motor neuron disease due to vitamin D deficiency and secondary hyperparathyroidism. Amytroph Lateral Scler Other Motor Neuron Disord. 2000, 1: 283-286. 10.1080\/14660820050515115.","journal-title":"Amytroph Lateral Scler Other Motor Neuron Disord"},{"key":"1255_CR25","doi-asserted-by":"publisher","first-page":"182","DOI":"10.7326\/0003-4819-80-2-182","volume":"80","author":"BM Patten","year":"1974","unstructured":"Patten BM, Bilezikian JP, Mallette LE, Prince A, Engel WK, Aurbach GD: Neuromuscular disease in primary hyperparathyroidism. Ann Intern Med. 1974, 80: 182-193.","journal-title":"Ann Intern Med"},{"key":"1255_CR26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/21548331.1992.11705484","volume":"27","author":"HJ Kaminski","year":"1992","unstructured":"Kaminski HJ, Ruff RL: Congenital disorders of neuromuscular transmission. Hosp Pract. 1992, 27: 73-81.","journal-title":"Hosp Pract"},{"key":"1255_CR27","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.7326\/0003-4819-68-5-1022","volume":"68","author":"B Frame","year":"1968","unstructured":"Frame B, Heinze EG, Block MA, Manson GA: Myopathy in primary hyperparathyroidism: observations in three patients. Ann Intern Med. 1968, 68: 1022-1027.","journal-title":"Ann Intern Med"},{"key":"1255_CR28","unstructured":"Singh NN, Thomas FP, Diamond AL, Diamond R: Vitamin B-12 associated neurological diseases. [ http:\/\/www.emedicine.com ]"},{"key":"1255_CR29","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/00005792-199107000-00001","volume":"70","author":"EB Healton","year":"1991","unstructured":"Healton EB, Savage DG, Brust JC: Neurologic aspects of cobalamin deficiency. Medicine (Baltimore). 1991, 70: 229-245.","journal-title":"Medicine (Baltimore)"},{"key":"1255_CR30","first-page":"1447","volume":"59","author":"T Kroliunitskaia","year":"1959","unstructured":"Kroliunitskaia T: On the treatment of patients with lateral amyotrophic sclerosis with vitamin B12. Zh Nevropatol Psikhiatr Im S S Korsakova. 1959, 59: 1447-1450.","journal-title":"Zh Nevropatol Psikhiatr Im S S Korsakova"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1752-1947-4-298\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-4-298.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-4-298","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-4-298.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T01:13:12Z","timestamp":1559524392000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/1752-1947-4-298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1255"],"URL":"https:\/\/doi.org\/10.1186\/1752-1947-4-298","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,1]]},"article-number":"298"}}